JB/CALL/POLE GROU/18/0.1667/21.03.25 Stock

PPZRJB

CH1311824036

Market Closed - Swiss Exchange 11:20:00 2024-07-01 EDT
2.16 ^CHF	+0.47%

Current month	+0.47%
1 month	-23.94%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart POLYPEPTIDE GROUP AG

Chart JB/CALL/POLE GROU/18/0.1667/21.03.25

Latest news about POLYPEPTIDE GROUP AG

PolyPeptide : and Donaldson collaborate to develop solvent recovery system for peptide purification	05-13	PU
Donaldson Company, Inc. and PolyPeptide Group AG Partners to Improve Sustainability in Peptide Manufacturing with Solvent Recovery Technology	05-13	CI
Hamlet BioPharma secures large scale Alpha1 peptide production in an agreement with Polypeptide Group	04-18	AQ
PolyPeptide announces results of the annual General Meeting 2024	04-10	EQ

More news

Quotes 5-day view

Date	Price	Change
24-07-01	2.16	+0.47%
24-06-28	2.15	-4.44%
24-06-27	2.25	+0.90%
24-06-26	2.23	-4.70%
24-06-25	2.34	-5.65%

Delayed Quote Swiss Exchange

Last update July 01, 2024 at 11:20 am

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	POLYPEPTIDE GROUP AG
Issuer	Bank Julius Bär
	PPZRJB
ISIN	CH1311824036
Date issued	2023-12-21
Strike	18 CHF
Maturity	2025-03-21 (263 Days)
Parity	6 : 1
Emission price	0.68 CHF
Emission volume	N/A
Settlement	les deux
Currency	CHF

Technical Indicators

Highest since issue	2.9 CHF
Lowest since issue	0.45 CHF
Delta	0.85x
Omega	1.889
Premium	7.78x
Gearing	2.21x
Moneyness	1.597
Difference Strike	-10.6 CHF
Difference Strike %	-58.89%
Spread	0.01 CHF
Spread %	0.46%
Theoretical value	2.165
Implied Volatility	78.85 %
Total Loss Probability	35.14 %
Intrinsic value	1.792
Present value	0.3730
Break even	30.99 CHF
Theta	-0.01x
Vega	0.01x
Rho	0.01x

Company Profile

Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.

Sector

More about the company

Ratings for PolyPeptide Group AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: PolyPeptide Group AG

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

29.51 EUR

Average target price

26.74 EUR

Spread / Average Target

-9.39%

Consensus